Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics CFO Marella Thorell resigns, effective November 15, 2026

Neutral Impact 4 of 5 leadership Written later

Seres Therapeutics said Chief Financial Officer Marella Thorell resigned from her executive vice president and CFO roles on October 22, 2026, effective November 15, 2026. The company said she is expected to provide advisory services after that date to support an orderly transition, on terms still to be agreed.

Key points

  • Marella Thorell resigned as EVP and Chief Financial Officer on October 22, 2026
  • Resignation takes effect November 15, 2026
  • Thorell is expected to provide advisory services to support an orderly transition, terms not yet agreed

The filing

CompanySeres Therapeutics, Inc. (MCRB)
Form8-K, current report
Filed with the SECOct 26, 2026, 4:30 PM ET
Accession number0001193125-26-432004

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.